Cognitive ability and brain structure in type 1 diabetes: Relation to microangiopathy and preceding severe hypoglycemia

Diabetes

Volumn 52, Issue 1, 2003, Pages 149-156

  Ferguson, Stewart C ^a   Blane, Annette ^a   Perros, Petros ^a   McCrimmon, Rory J ^a   Best, Jonathan J K ^a   Wardlaw, Joanna ^b   Deary, Ian J ^b   Frier, Brian M ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ARTIFICIAL INTELLIGENCE; ATTENTION; BASAL GANGLION; BRAIN; COGNITION; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTELLIGENCE; LEARNING; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; WHITE MATTER;

ADULT; BRAIN; COGNITION; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FEMALE; HUMANS; HYPOGLYCEMIA; MAGNETIC RESONANCE IMAGING; MALE; MEDICAL RECORDS; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX;

EID: 0037219230     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.1.149     Document Type: Article

References (54)

1. The Diabetes Control and Complications Trial Research Group: Hypoglycemia in the diabetes control and complications trial. Diabetes 46:271-286, 1997
2. Agardh CD, Rosen I, Ryding E: Persistent vegetative state with high cerebral blood flow following profound hypoglycemia. Ann Neurol 14:482-486, 1983
3. Chalmers J, Risk MT, Kean DM, Grant R, Ashworth B, Campbell IW: Severe anmesia after hypoglycemia: Clinical, psychometric, and magnetic resonance imaging correlations. Diabetes Care 14:922-925, 1991
4. Perros P, Sellar RJ, Frier BM: Chronic pontine dysfunction following insulin-induced hypoglycemia in an IDDM patient. Diabetes Care 17:725-727, 1994
5. Boeve BF, Bell DG, Noseworthy JH: Bilateral temporal lobe MRI changes in uncomplicated hypoglycemic coma. Can J Neurol Sci 22:56-58, 1995
6. Rajbhandari SM, Powell T, Davies-Jones GA, Ward JD: Central pontine myelinolysis and ataxia: An unusual manifestation of hypoglycaemia. Diabet Med 15:259-261, 1998
7. Casey E, Evans A, Krentz A, Watkins P, Hopkins D: Central pontine myelinolysis: An unusual complication of diabetes. Diabetes Care 22:998-1000, 1999
8. Auer RN, Siesjo BK: Hypoglycaemia: Brain neurochemistry and neuropathology. Baillieres Clin Endocrinol Metab 7:611-625, 1993
9. Strachan MW, Deary IJ, Ewing FM, Frier BM: Recovery of cognitive function and mood after severe hypoglycemia in adults with insulin-treated diabetes. Diabetes Care 23:305-312, 2000
10. Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial. Ann Intern Med 124:379-388, 1996
11. Reichard P, Pihl M, Rosenqvist U, Sule J: Complications in IDDM are caused by elevated blood glucose level: The Stockholm Diabetes Intervention Study (SDIS) at 10-year follow up. Diabetologia 39:1483-1488, 1996
12. Austin EJ, Deary IJ: Effects of repeated hypoglycemia on cognitive function: A psychometrically validated reanalysis of the Diabetes Control and Complications Trial data. Diabetes Care 22:1273-1277, 1999
13. Wredling R, Levander S, Adamson U, Lins PE: Permanent neuropsychological impairment after recurrent episodes of severe hypoglycaemia in man. Diabetologia 33:152-157, 1990
14. Langan SJ, Deary IJ, Hepburn DA, Frier BM: Cumulative cognitive impairment following recurrent severe hypoglycaemia in adult patients with insulin-treated diabetes mellitus. Diabetologia 34:337-344, 1991
15. Sachon C, Grimaldi A, Digy JP, Pillon B, Dubois B, Thervet F: Cognitive function, insulin-dependent diabetes and hypoglycaemia. J Intern Med 231:471-475, 1992
16. Lincoln NB, Faleiro RM, Kelly C, Kirk BA, Jeffcoate WJ: Effect of long-term glycemic control on cognitive function. Diabetes Care 19:656-658, 1996
17. Perros P, Deary IJ, Sellar RJ, Best JJ, Frier BM: Brain abnormalities demonstrated by magnetic resonance imaging in adult IDDM patients with and without a history of recurrent severe hypoglycemia. Diabetes Care 20:1013-1018, 1997
18. Grunnet M: Cerebrovascular disease: Diabetes and cerebral atherosclerosis. Neurology 13:486-491, 1963
19. Reske-Nielsen E, Lundbaek K: Diabetic encephalopathy: Diffuse and focal lesions of the brain in long-term diabetes. Acta Neurol Scand 39 (Suppl. 4):273-290, 1963
20. Dejgaard A, Gade A, Larsson H, Balle V, Parving A: Evidence for diabetic encephalopathy. Diabet Med 8:162-167, 1991
21. McCall AL: The impact of diabetes on the CNS. Diabetes 41:557-570, 1992
22. Yousem DM, Tasman WS, Grossman RI: Proliferative retinopathy: Absence of white matter lesions at MR imaging. Radiology 179:229-230, 1991
23. Lunetta M, Damanti AR, Fabbri G, Lombardo M, Di Mauro M, Mughini L: Evidence by magnetic resonance imaging of cerebral alterations of atrophy type in young insulin-dependent diabetic patients. J Endocrinol Invest 17:241-245, 1994
24. Pantoni L, Garcia JH: The significance of cerebral white matter abnormalities 100 years after Binswanger's report: A review. Stroke 26:1293-1301, 1995
25. Ryan CM, Becker DJ: Hypoglycemia in children with type 1 diabetes mellitus: Risk factors, cognitive function, and management. Endocrinol Metab Clin North Am 28:883-900, 1999
26. Early Treatment Diabetic Retinopathy Study Research Group: Grading diabetic retinopathy from stereoscopic color fundus photographs: An extension of the modified Airlie House classification: ETDRS report number 10. Ophthalmology 98:786-806, 1991
27. Deary IJ, Crawford JR, Hepburn DA, Langan SJ, Blackmore LM, Frier BM: Severe hypoglycemia and intelligence in adult patients with insulin-treated diabetes. Diabetes 42:341-344, 1993
28. Lawrie SM, Whalley H, Kestelman JN, Abukmeil SS, Byrne M, Hodges A, Rimmington JE, Best JJ, Owens DG, Johnstone EC: Magnetic resonance imaging of brain in people at high risk of developing schizophrenia. Lancet 353:30-33, 1999
29. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA: MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 149:351-356, 1987
30. Shimada K, Kawamoto A, Matsubayashi K, Ozawa T: Silent cerebrovascular disease in the elderly: Correlation with ambulatory pressure. Hypertension 16:692-699, 1990
31. Wahlund LO, Agartz I, Almqvist O, Basun H, Forssell L, Saaf J, Wetterberg L: The brain in healthy aged individuals: MR imaging. Radiology 174:675-679, 1990
32. Van Swieten JC, Hijdra A, Koudstaal PJ, van Gijn J: Grading white matter lesions on CT and MRI: A simple scale. J Neurol Neurosurg Psychiatry 53:1080-1083, 1990
33. Mirsen TR, Lee DH, Wong CJ, Diaz JF, Fox AJ, Hachinski VC, Merskey H: Clinical correlates of white-matter changes on magnetic resonance imaging scans of the brain. Arch Neurol 48:1015-1021, 1991
34. Breteler MM, Van Swieten JC, Bots ML, Grobbee DE, Claus JJ, van den Hout JH, van Harskamp F, Tanghe HL, de Jong PT, van Gijn J: Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 44:1246-1252, 1994
35. Breteler MM, van Amerongen NM, Van Swieten JC, Claus JJ, Grobbee DE, van Gijn J, Hofman A, van Harskamp F: Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging: The Rotterdam Study. Stroke 25:1109-1115, 1994
36. Longstreth WT, Jr, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, Enright PL, O'Leary D, Fried L: Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: The cardiovascular health study. Stroke 27:1274-1282, 1996
37. Mantyla R, Erkinjuntti T, Salonen O, Aronen HJ, Peltonen T, Pohjasvaara T, Standertskjold-Nordenstam CG: Variable agreement between visual rating scales for white matter hyperintensities on MRI: Comparison of 13 rating scales in a poststroke cohort. Stroke 28:1614-1623, 1997
38. Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361-370, 1983
39. Wechsler D: Manual for the Wechsler Adult Intelligence Scale-Revised. New York, Psychological Corporation, 1981
40. Nelson HE, Willison JR: National Adult Reading Test (NART) Test Manual. 2nd ed. Windsor, U.K., NFER-Nelson, 1991
41. McCrimmon RJ, Deary IJ, Huntly BJH, MacLeod KJM, Frier BM: Visual information processing during controlled hypoglycaemia in humans. Brain 119:1277-1287, 1996
42. Jensen AR: Individual differences in the Hick paradigm. In Speed of Information Processing and Intelligence. Vernon PA, Ed. Norwood, NJ, Ablex, 1987
43. Borkowski JG, Benton AL: Word fluency and brain damage. Neuropsychologia 5:135-140, 1967
44. Deary IJ, Langan SJ, Hepburn DA, Frier BM: Which abilities does the PASAT test? Pers Indiv Diff 12:983-987, 1991
45. Ryan CM, Williams TM, Finegold DN, Orchard TJ: Cognitive dysfunction in adults with type 1 (insulin-dependent) diabetes mellitus of long duration: Effects of recurrent hypoglycaemia and other chronic complications. Diabetologia 36:329-334, 1993
46. Orchard TJ, Forrest KY, Ellis D, Becker DJ: Cumulative glycemic exposure and microvascular complications in insulin-dependent diabetes mellitus: The glycemic threshold revisited. Arch Intern Med 157:1851-1856, 1997
47. Parisi V, Uccioli L, Montocone G, Parisi L, Menzinger G, Bucci MG: Visual evoked potentials after photostress in insulin-dependent diabetic patients with or without retinopathy. Graefes Arch Clin Exp Ophthalmol 232:193-198, 1994
48. Ball MJ: "Leukoaraiosis" explained. Lancet 1:612-613, 1989
49. Bellassoued M, Mhiri C, Triki C, Abid M: Hemichorea caused by striatal infarct in a young type 1 diabetic patient. Rev Neurol (Paris) 157:1287-1289, 2001
50. Ertl-Wagner B, Jansen O, Schwab S, Sartor K: Bilateral basal ganglion haemorrhage in diabetic ketoacidotic coma: Case report. Neuroradiology 41:670-673, 1999
51. Rogers B, Sills I, Cohen M, Seidel FG: Diabetic ketoacidosis: neurologic collapse during treatment followed by severe developmental morbidity. Clin Pediatr (Phila) 29:451-456, 1990
52. Wong TY, Klein R, Couper DJ, Cooper LS, Shahar E, Hubbard LD, Wofford MR, Sharrett AR: Retinal microvascular abnormalities and incident stroke: The Atherosclerosis Risk in Communities Study. Lancet 358:1134-1140, 2001
53. Le Bihan D, Jezzard P, Haxby J, Sadato N, Rueckert L, Mattay V: Functional magnetic resonance imaging of the brain. Ann Intern Med 122:296-303, 1995
54. Fulesdi B, Limburg M, Bereczki D, Michels RP, Neuwirth G, Legemate D, Valikovics A, Csiba L: Impairment of cerebrovascular reactivity in long-term type 1 diabetes. Diabetes 46:1840-1845, 1997